Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$48.86

-1.74 (-3.44%)

07:00
10/25/18
10/25
07:00
10/25/18
07:00

Bristol-Myers reports Q3 EPS $1.09, consensus 91c

Reports Q revenue $5.69B, consensus $5.72B.

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

BMY Bristol-Myers
$48.86

-1.74 (-3.44%)

10/22/18
SBSH
10/22/18
DOWNGRADE
Target $57
SBSH
Neutral
Citi sees Merck showing 'extraordinary' treatment effect, downgrades Bristol
Citi analyst Andrew Baum downgraded Bristol-Myers Squibb (BMY) to Neutral from Buy and lowered his price target for the shares to $57 from $62. The drugmaker closed Friday down 3%, or $1.72, to $54.30. The downgrade largely reflects further likely "lowering of floor" Opdivo, Yervoy and earnings estimates from a base that is already materially below the consensus, Baum tells investors in a research note partially titled "The Final Straws." The analyst anticipates an "extraordinary" treatment effect from Keytruda in Merck's (MRK) Keynote-426 trial in renal cell carcinoma given the statistical significance for both progression-free survival and overall survival at the first interim analysis.
10/22/18
HCWC
10/22/18
NO CHANGE
Target $54
HCWC
Neutral
Roche data should concern Nektar bulls, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay believes Roche's (RHHBY) preliminary data of RO6875281, a fibroblast activation protein targeted interleukin-2 variant, should concern the bulls of Nektar Therapeutics (NKTR). The 11% and 20% overall response rate for single agent RO6875281 in squamous cell head and neck cancer and melanoma is compelling, Chattopadhyay tells investors in a research note. Nektar's NKTR-214 had no monotherapy activity, and the early promise in combination with Opdivo "has faded potentially due to its limited PK profile," the analyst adds. In addition, Chattopadhyay believes the monotherapy activity with pegilodecakin, a pegylated IL-10 being developed by Eli Lily (LLY), further complicates the competitive landscape for NKTR-214. He believes the second generation of "not alpha" IL-2, which is poised to enter the clinic during 2019, could further "upend" NKTR-214 and might compel Nektar's partner Bristol-Myers Squibb (BMY) to "re-evaluate the aggressive development strategy that was outlined earlier this year." The analyst keeps a Neutral rating on Nektar with a $54 price target.
10/22/18
10/22/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. eBay (EBAY) downgraded to Neutral from Buy at Monness Crespi and BofA/Merrill. 2. Bristol-Myers (BMY) downgraded to Neutral from Buy at Citi. 3. Manpower (MAN) downgraded to Neutral from Overweight at JPMorgan with analyst Andrew Steinerman saying he "misjudged the magnitude" of the European softness for the company as its Q4 financial guidance suggests a down 2% year-over-year same day basis revenue decline. 4. Reliance Steel (RS) downgraded to Neutral from Buy at Longbow with analyst Chris Olin citing near-term risks from unfavorable nonferrous demand/price momentum following a collection of relatively weak data points from the firm's carbon and stainless steel surveys. 5. Wingstop (WING) downgraded to Neutral from Outperform at Wedbush with analyst Nick Setyan saying he continues to believe drivers of same-store sales growth, unit growth, and margin upside relative to current consensus 2018 and 2019 estimates exist. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/18
WOLF
10/23/18
INITIATION
Target $66
WOLF
Outperform
Bristol-Myers reinitiated with an Outperform at Wolfe Research
Wolfe Research analyst Time Anderson reinitiated Bristol-Myers with an Outperform and $66 price target.

TODAY'S FREE FLY STORIES

MMP

Magellan Midstream

$62.18

0.06 (0.10%)

13:57
06/25/19
06/25
13:57
06/25/19
13:57
Periodicals
Magellan seeking sale of stake in Longhorn crude pipeline, Reuters says »

Magellan Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/25/19
06/25
13:55
06/25/19
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

MMP

Magellan Midstream

$62.21

0.09 (0.14%)

13:48
06/25/19
06/25
13:48
06/25/19
13:48
Periodicals
Magellan Midstream seeks to sell Longhorn pipeline stake, Reuters says »

Magellan Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$8.32

-0.15 (-1.77%)

13:45
06/25/19
06/25
13:45
06/25/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

13:45
06/25/19
06/25
13:45
06/25/19
13:45
General news
Treasury Action: yields are flat to lower after Fed comments »

Treasury Action: yields…

GIS

General Mills

$53.74

0.08 (0.15%)

, PAYX

Paychex

$85.15

-1.02 (-1.18%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$53.74

0.08 (0.15%)

PAYX

Paychex

$85.15

-1.02 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

FDX

FedEx

$156.37

-4.51 (-2.80%)

, MU

Micron

$33.30

0.12 (0.36%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting after market close »

Notable companies…

FDX

FedEx

$156.37

-4.51 (-2.80%)

MU

Micron

$33.30

0.12 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

13:37
06/25/19
06/25
13:37
06/25/19
13:37
Periodicals
Presidents Trump, Xi to meet Saturday in Japan, Reuters says »

Presidents Trump and Xi…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.05

-0.93 (-2.33%)

13:35
06/25/19
06/25
13:35
06/25/19
13:35
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary at Stifel »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$82.69

1.85 (2.29%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
06/25/19
06/25
13:25
06/25/19
13:25
General news
Fed Chair Powell repeated the phrase from the FOMC that the Fed is "closely monitoring »

Fed Chair Powell repeated…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

, ETFC

E-Trade

$44.43

-0.14 (-0.31%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

ETFC

E-Trade

$44.43

-0.14 (-0.31%)

SCHW

Charles Schwab

$39.22

0.07 (0.18%)

AMTD

TD Ameritrade

$48.32

0.23 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

13:20
06/25/19
06/25
13:20
06/25/19
13:20
General news
FX Action: The DXY rallied »

FX Action: The DXY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/25/19
06/25
13:17
06/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/25/19
06/25
13:16
06/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$23.90

-1.52 (-5.98%)

13:15
06/25/19
06/25
13:15
06/25/19
13:15
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/25/19
06/25
13:15
06/25/19
13:15
General news
Treasury's $40 B 2-year auction was mixed as a confluence of factors impacted »

Treasury's $40 B…

ASOMY

Asos

$0.00

(0.00%)

13:11
06/25/19
06/25
13:11
06/25/19
13:11
Downgrade
Asos rating change  »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$33.46

0.28 (0.84%)

13:08
06/25/19
06/25
13:08
06/25/19
13:08
On The Fly
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

13:08
06/25/19
06/25
13:08
06/25/19
13:08
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:07
06/25/19
06/25
13:07
06/25/19
13:07
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

MDR

McDermott

$8.82

0.6 (7.30%)

13:05
06/25/19
06/25
13:05
06/25/19
13:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.